Gain key clinical insights fast, with this short slideset from CCO on key considerations for optimal use of anti-BMCA therapy for patients with relapsed/refractory multiple myeloma.
Watch a short video that provides an expert review of the evolution in CLL treatment over the past several years, from Clinical Care Options (CCO)
In slides from Clinical Care Options (CCO), gain expert insights into the evolution in CLL treatment over the past several years
Comentario experto de los datos de la EHA 2022 sobre inhibidores de la QBT para LLC y LCM de Clinical Care Options (CCO)
Expertengespräch über die Daten der EHA 2022 zu BTK-Inhibitoren für CLL und MCL, von Clinical Care Options (CCO)